These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15848192)

  • 1. Modified nicotine metabolism in transgenic tobacco plants expressing the human cytochrome P450 2A6 cDNA.
    Dueckershoff K; Unger M; Frank A; Gillam EM; Guengerich FP; Warzecha H
    FEBS Lett; 2005 Apr; 579(11):2480-4. PubMed ID: 15848192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of the indigo precursor indican in genetically engineered tobacco plants and cell cultures.
    Warzecha H; Frank A; Peer M; Gillam EM; Guengerich FP; Unger M
    Plant Biotechnol J; 2007 Jan; 5(1):185-91. PubMed ID: 17207267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of cytochrome P450 2A6 polymorphism in nicotine metabolism and tobacco-dependent behaviour].
    Xia XY; Peng RX
    Yao Xue Xue Bao; 2004 Sep; 39(9):758-63. PubMed ID: 15606031
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
    Dempsey D; Tutka P; Jacob P; Allen F; Schoedel K; Tyndale RF; Benowitz NL
    Clin Pharmacol Ther; 2004 Jul; 76(1):64-72. PubMed ID: 15229465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
    Mwenifumbo JC; Tyndale RF
    Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
    Nakajima M; Kuroiwa Y; Yokoi T
    Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
    Yoshida R; Nakajima M; Nishimura K; Tokudome S; Kwon JT; Yokoi T
    Clin Pharmacol Ther; 2003 Jul; 74(1):69-76. PubMed ID: 12844137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes.
    Murphy SE; Raulinaitis V; Brown KM
    Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
    Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6.
    Nakajima M; Itoh M; Yamanaka H; Fukami T; Tokudome S; Yamamoto Y; Yamamoto H; Yokoi T
    J Clin Pharmacol; 2006 Mar; 46(3):337-44. PubMed ID: 16490810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human cytochrome P4502A6 in C-oxidation of nicotine.
    Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
    Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism.
    Murphy SE; Johnson LM; Pullo DA
    Chem Res Toxicol; 1999 Jul; 12(7):639-45. PubMed ID: 10409404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
    Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.
    Swan GE; Benowitz NL; Lessov CN; Jacob P; Tyndale RF; Wilhelmsen K
    Pharmacogenet Genomics; 2005 Feb; 15(2):115-25. PubMed ID: 15861035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
    Fukami T; Nakajima M; Yoshida R; Tsuchiya Y; Fujiki Y; Katoh M; McLeod HL; Yokoi T
    Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
    Hukkanen J; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.